UnitedHealth Group (NYSE:UNH) had its price target raised by Cantor Fitzgerald from $310.00 to $315.00 in a research note released on Wednesday, AnalystRatings.com reports. They currently have a buy rating on the healthcare conglomerate’s stock. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2019 earnings at $14.99 EPS.
UNH has been the subject of several other reports. Deutsche Bank began coverage on UnitedHealth Group in a research note on Thursday, September 12th. They set a hold rating and a $263.00 price objective for the company. Wells Fargo & Co increased their target price on UnitedHealth Group from $288.00 to $318.00 and gave the company an in-line rating in a report on Wednesday. Jefferies Financial Group downgraded UnitedHealth Group from a buy rating to a hold rating and decreased their target price for the company from $300.00 to $235.00 in a research report on Thursday, October 10th. SunTrust Banks reaffirmed a buy rating and issued a $335.00 price target (up from $310.00) on shares of UnitedHealth Group in a research note on Monday, November 18th. Finally, UBS Group dropped their price target on UnitedHealth Group from $281.00 to $257.00 and set a neutral rating for the company in a research report on Thursday, October 17th. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. UnitedHealth Group currently has an average rating of Buy and an average price target of $299.35.
UNH opened at $280.19 on Wednesday. The firm’s fifty day simple moving average is $262.08 and its two-hundred day simple moving average is $246.14. UnitedHealth Group has a 52-week low of $208.07 and a 52-week high of $283.04. The company has a market cap of $265.46 billion, a price-to-earnings ratio of 21.75, a PEG ratio of 1.48 and a beta of 0.64. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, topping analysts’ consensus estimates of $3.75 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The business had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. During the same quarter in the previous year, the company earned $3.41 earnings per share. The company’s quarterly revenue was up 6.7% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group will post 14.96 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $1.08 dividend. The ex-dividend date of this dividend is Friday, December 6th. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Tuesday, September 17th. The stock was sold at an average price of $232.76, for a total transaction of $581,900.00. Following the transaction, the director now owns 187,979 shares of the company’s stock, valued at $43,753,992.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Thomas E. Roos sold 1,177 shares of the company’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at $5,531,052.48. The disclosure for this sale can be found here. In the last ninety days, insiders sold 38,577 shares of company stock valued at $9,398,080. Insiders own 0.82% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of UNH. Selective Wealth Management Inc. acquired a new position in UnitedHealth Group in the 3rd quarter valued at about $27,000. North Star Investment Management Corp. purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $30,000. Delta Asset Management LLC TN increased its holdings in shares of UnitedHealth Group by 111.0% during the 3rd quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 81 shares during the last quarter. Fusion Family Wealth LLC increased its holdings in shares of UnitedHealth Group by 329.7% during the 3rd quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 122 shares during the last quarter. Finally, Massey Quick Simon & CO. LLC increased its holdings in shares of UnitedHealth Group by 212.5% during the 3rd quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 119 shares during the last quarter. 85.50% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: How do taxes affect a CDs total return?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.